Template:Acute spinal cord injury treatment

Revision as of 14:46, 4 February 2015 by Rossdonaldson1 (talk | contribs) (Created page with "*Assess for stability **Cervical Spine Injuries **Thoracic and Lumbar Spinal Injuries *Consider intubation for pt w/ injury at C5 or above *Steroids are no longer reco...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Steroids

"Administration of methylprednisolone (MP) for the treatment of acute spinal cord injury (SCI) is not recommended. Clinicians considering MP therapy should bear in mind that the drug is not Food and Drug Administration (FDA) approved for this application. There is no Class I or Class II medical evidence supporting the clinical benefit of MP in the treatment of acute SCI. Scattered reports of Class III evidence claim inconsistent effects likely related to random chance or selection bias. However, Class I, II, and III evidence exists that high-dose steroids are associated with harmful side effects including death."

—Pharmacological therapy for acute spinal cord injury., Neurosurgery. 2013 Mar;72 Suppl 2:93-105[1]
  1. Hurlbert RJ et al. Pharmacological therapy for acute spinal cord injury. Neurosurgery. 2013 Mar;72 Suppl 2:93-105 http://www.ncbi.nlm.nih.gov/pubmed/23417182